Our Business
We are a premier provider of specialized and sustainable material solutions that
transform customer challenges into opportunities, bringing new products to life
for a better world. Our products include specialty engineered materials,
advanced composites, color and additive systems and polymer distribution. We are
also a highly specialized developer and manufacturer of performance enhancing
additives, liquid colorants, and fluoropolymer and silicone colorants.
Headquartered in Avon Lake, Ohio, we have employees at sales, manufacturing and
distribution facilities across the globe. We provide value to our customers
through our ability to link our knowledge of polymers and formulation technology
with our manufacturing and supply chain capabilities to provide value-added
solutions to designers, assemblers and processors of plastics. When used in this
Quarterly Report on Form 10-Q, the terms "we," "us," "our," "Avient" and the
"Company" mean Avient Corporation, formerly known as PolyOne Corporation, and
its consolidated subsidiaries.
Highlights and Executive Summary
A summary of Avient's sales, operating income, net income and net income
attributable to Avient common shareholders follows:
                                                      Three Months Ended                      Six Months Ended
                                                           June 30,                               June 30,
(In millions)                                       2021                2020               2021               2020
Sales                                          $   1,235.2          $   609.1          $ 2,397.5          $ 1,320.6
Operating income                                     108.1               38.0              228.5               90.8
Net income from continuing operations                 69.4               23.4              149.1               56.5
Income (loss) from discontinued operations,
net of income taxes                                      -               (0.2)                 -               (0.5)
Net income                                     $      69.4          $    23.2          $   149.1          $    56.0

Net income attributable to Avient common
shareholders                                   $      68.8          $    22.8          $   148.1          $    55.6


Trends and Developments
COVID-19
We have continued to closely monitor the impact of the COVID-19 pandemic on all
aspects of our business, including how it has impacted our employees, customers,
supply chain and distribution network. While our business was adversely affected
by the COVID-19 pandemic in 2020, we have seen recovery through the second
quarter of 2021. The scope and duration of the pandemic continues to be
uncertain, and evolving factors such as the level and timing of vaccine
distribution across the world and the extent of any resurgences of the virus or
emergence of new variants will impact the stability of the economic recovery and
growth. The extent to which our operations may be adversely impacted by the
COVID-19 pandemic will depend largely on these future developments, which are
highly uncertain and cannot be accurately predicted. For further information
regarding the impact that COVID-19 could have on our business, see Part I - Item
1A. Risk Factors in our Annual Report on Form 10-K for the year ended December
31, 2020.
Clariant MB Acquisition
On July 1, 2020, the Company completed the Clariant MB Acquisition. The Clariant
MB Acquisition increased the Company's scale, product depth and geographic reach
in its Color, Additives and Inks segment. Clariant MB has leading portfolios of
solid and liquid masterbatches that include sustainable solutions for
alternative energy, and reduced material requirements for packaging and light
weighting.
Total consideration paid by the Company to complete the Clariant MB Acquisition
was $1.4 billion, net of cash and debt acquired. To finance the purchase of
Clariant MB, the Company used $496.1 million in net proceeds from the issuance
of common shares in an underwritten public offering completed in February 2020
and $640.5 million in net proceeds from a senior unsecured notes offering
completed in May 2020, and funded the balance using the net proceeds of the
October 2019 sale of our Performance Products and Solutions business segment
(PP&S). We finalized the purchase accounting for the Clariant MB Acquisition as
of June 30, 2021. For details related to the effects of adjustments recognized
in the current reporting period, refer to Note 2, Business Combinations to the
accompanying condensed consolidated financial statements.

17 AVIENT CORPORATION
--------------------------------------------------------------------------------

Results of Operations - The three and six months ended June 30, 2021 compared to three and six months ended June 30, 2020:


                                                                                                                                                                                 Variances -
                                          Three Months Ended June 30,          Variances - Favorable (Unfavorable)             Six Months Ended June 30,                   Favorable (Unfavorable)
(Dollars in millions, except per share                                                                      %                                                                                     %
data)                                        2021               2020                Change                Change                2021                  2020                Change                Change
Sales                                    $  1,235.2          $ 609.1          $         626.1                103  %       $      2,397.5          $ 1,320.6          $      1,076.9                 82  %
Cost of sales                                 946.5            459.4                   (487.1)              (106) %              1,806.4              999.4                  (807.0)               (81) %
Gross margin                                  288.7            149.7                    139.0                 93  %                591.1              321.2                   269.9                 84  %
Selling and administrative expense            180.6            111.7                    (68.9)               (62) %                362.6              230.4                  (132.2)               (57) %

Operating income                              108.1             38.0                     70.1                184  %                228.5               90.8                   137.7                152  %
Interest expense, net                         (19.5)           (16.2)                    (3.3)               (20) %                (38.8)             (25.6)                  (13.2)               (52) %

Other income, net                               1.2              9.5                     (8.3)              nm                       2.7               11.1                    (8.4)              nm
Income from continuing operations before
income taxes                                   89.8             31.3                     58.5                187  %                192.4               76.3                   116.1                152  %
Income tax expense                            (20.4)            (7.9)                   (12.5)              (158) %                (43.3)             (19.8)                  (23.5)              (119) %
Net income from continuing operations          69.4             23.4                     46.0                197  %                149.1               56.5                    92.6                164  %
Loss from discontinued operations, net
of income taxes                                   -             (0.2)                     0.2               nm                         -               (0.5)                    0.5               nm
Net income                                     69.4             23.2                     46.2                199  %                149.1               56.0                    93.1                166  %
Net income attributable to
noncontrolling interests                       (0.6)            (0.4)                    (0.2)              nm                      (1.0)              (0.4)                   (0.6)              nm
Net income attributable to Avient common
shareholders                             $     68.8          $  22.8          $          46.0                202  %       $        148.1          $    55.6          $         92.5                166  %

Earnings per share attributable to Avient common shareholders - Basic:
Continuing operations                    $     0.75          $  0.25                                                      $         1.62          $    0.63
Discontinued operations                           -                -                                                                   -                  -
Total                                    $     0.75          $  0.25                                                      $         1.62          $    0.63

Earnings (loss) per share attributable to Avient common shareholders - Diluted:
Continuing operations                    $     0.74          $  0.25                                                      $         1.60          $    0.63
Discontinued operations                           -                -                                                                   -              (0.01)
Total                                    $     0.74          $  0.25                                                      $         1.60          $    0.62


nm - not meaningful

Sales
Sales increased $626.1 million and $1,076.9 million in the three and six months
ended June 30, 2021 compared to the three and six months ended June 30, 2020,
respectively, as a result of the Clariant MB Acquisition as well as demand
recovery in many end markets and price increases associated with raw material
inflation.
Cost of sales
Cost of sales increased from 75.4% as a percentage of sales in the three months
ended June 30, 2020 to 76.6% in the three months ended June 30, 2021 as a result
of rising raw material costs partially offset by improved mix. Cost of sales
decreased from 75.7% as a percentage of sales in the six months ended June 30,
2020 to 75.3% in the six months ended June 30, 2021 as a result of improved mix.
Selling and administrative expense
Selling and administrative expense increased $68.9 million and $132.2 million
during the three and six months ended June 30, 2021 compared to the three and
six months ended June 30, 2020, respectively, driven primarily by the Clariant
MB Acquisition.


18 AVIENT CORPORATION

--------------------------------------------------------------------------------

Interest expense, net
Interest expense, net, increased $3.3 million and $13.2 million during the three
and six months ended June 30, 2021 compared to the three and six months ended
June 30, 2020, respectively, due to higher interest expense related to our
senior unsecured notes offering completed in May 2020.
Income taxes
During the three and six months ended June 30, 2021, the Company's effective tax
rate was 22.6% and 22.5%, respectively, compared to 25.1% and 25.9% for the
three and six months ended June 30, 2020, respectively. The income tax rate
decrease is primarily due to a lower tax effect of GILTI tax, lower tax impact
on withholding tax associated with the future repatriation of certain current
year foreign earnings, lower valuation allowance expense, favorable comparable
benefits of a tax rate change and favorable prior year foreign
return-to-provision adjustments. Partially offsetting these favorable effects
was a more favorable foreign effective tax rate in 2020 compared to 2021 and a
higher impact of state income taxes in 2021.
SEGMENT INFORMATION
Avient has three reportable segments: (1) Color, Additives and Inks; (2)
Specialty Engineered Materials; and (3) Distribution. Operating income is the
primary measure that is reported to our chief operating decision maker (CODM)
for purposes of allocating resources to the segments and assessing their
performance.
Sales and Operating Income - The three and six months ended June 30, 2021
compared to the three and six months ended June 30, 2020:
                                                                                        Variances - Favorable                                                                       Variances - Favorable
                                         Three Months Ended June 30,                        (Unfavorable)                           Six Months Ended June 30,                           (Unfavorable)
(Dollars in millions)                       2021                 2020               Change               %  Change                 2021                     2020                Change                %  Change

Sales:


Color, Additives and Inks            $        624.4           $ 226.8          $       397.6                    175  %       $    1,233.7               $   483.3          $        750.4                    155  %
Specialty Engineered Materials                240.6             158.8                   81.8                     52  %              457.1                   344.1                   113.0                     33  %
Distribution                                  404.4             238.8                  165.6                     69  %              767.1                   528.3                   238.8                     45  %
Corporate and eliminations                    (34.2)            (15.3)                 (18.9)                  (124) %              (60.4)                  (35.1)                  (25.3)                   (72) %
Total Sales                          $      1,235.2           $ 609.1          $       626.1                    103  %       $    2,397.5               $ 1,320.6          $      1,076.9                     82  %

Operating income:
Color, Additives and Inks            $         86.3           $  32.3          $        54.0                    167  %       $      175.1               $    72.8          $        102.3                    141  %
Specialty Engineered Materials                 37.3              17.0                   20.3                    119  %               71.5                    39.3                    32.2                     82  %
Distribution                                   23.7              14.6                    9.1                     62  %               47.7                    34.0                    13.7                     40  %
Corporate and eliminations                    (39.2)            (25.9)                 (13.3)                   (51) %              (65.8)                  (55.3)                  (10.5)                   (19) %
Total Operating Income               $        108.1           $  38.0          $        70.1                    184  %       $      228.5               $    90.8          $        137.7                    152  %

Operating income as a percentage of sales:
Color, Additives and Inks                      13.8   %          14.2  %                (0.4)         % points                       14.2   %                15.1  %                 (0.9)         % points
Specialty Engineered Materials                 15.5   %          10.7  %                 4.8          % points                       15.6   %                11.4  %                  4.2          % points
Distribution                                    5.9   %           6.1  %                (0.2)         % points                        6.2   %                 6.4  %                 (0.2)         % points
Total                                           8.8   %           6.2  %                 2.6          % points                        9.5   %                 6.9  %                  2.6          % points



Color, Additives and Inks
Sales increased $397.6 million and $750.4 million in the three and six months
ended June 30, 2021 compared to the three and six months ended June 30, 2020,
respectively. These increases were driven primarily by the Clariant MB
Acquisition, as well as demand recovery in many end markets.
On a pro forma basis to include Clariant MB in all periods, sales increased by
$136.5 million in the three months ended June 30, 2021, compared to the three
months ended June 30, 2020 as a result of demand recovery in many end markets,
particularly consumer, transportation, and industrial as well as price
increases. On a pro forma basis to include Clariant MB in all periods, sales
increased by $209.9 million, or 21%, in the six months ended June 30, 2021
compared to the six months ended June 30, 2020 as a result of demand recovery in
many end markets, particularly consumer, transportation, and industrial, and
price increases.

19 AVIENT CORPORATION
--------------------------------------------------------------------------------

Operating income increased $54.0 million and $102.3 million in the three and six
months ended June 30, 2021 as compared to the three and six months ended
June 30, 2020, respectively. These increases were driven primarily by the
Clariant MB Acquisition, as well as demand recovery in many end markets.
On a pro forma basis to include Clariant MB in all periods, operating income
increased by 57% and 48% in the three and six months ended June 30, 2021,
compared to the three and months ended June 30, 2020, respectively, as a result
of the sales growth discussed above and capture of integration synergies,
partially offset by raw material and conversion cost inflation.
Specialty Engineered Materials
Sales increased $81.8 million and $113.0 million in the three and six months
ended June 30, 2021 compared to the three and six months ended June 30, 2020,
respectively, largely driven by high demand for composite materials and recovery
in many end markets.
Operating income increased $20.3 million and $32.2 million in the three and six
months ended June 30, 2021 as compared to the three and six months ended
June 30, 2020, respectively, due to the increased sales and continued growth of
higher margin specialty and composite solutions.
Distribution
Sales increased $165.6 million and $238.8 million in the three and six months
ended June 30, 2021, respectively, as compared to the three and six months ended
June 30, 2020, driven by increased demand as well as inflation.
Operating income increased $9.1 million and $13.7 million in the three and six
months ended June 30, 2021 as compared to the three and six months ended
June 30, 2020 largely driven by increased demand.
Corporate and Eliminations
Operating income increased $13.3 million, or 51%, in the three months ended
June 30, 2021 as compared to the three months ended June 30, 2020 and $10.5
million, or 19%, in the six months ended June 30, 2021 as compared to the six
months ended June 30, 2020 due to higher environmental remediation costs,
partially offset by lower acquisition related and restructuring expense.
Liquidity and Capital Resources
Our objective is to finance our business through operating cash flow and an
appropriate mix of debt and equity. By laddering the maturity structure, we
avoid concentrations of debt maturities, reducing liquidity risk. We may from
time to time seek to retire or purchase our outstanding debt with cash and/or
exchanges for equity securities, in open market purchases, privately negotiated
transactions or otherwise. We may also seek to repurchase our outstanding common
shares. Such repurchases, if any, will depend on prevailing market conditions,
our liquidity requirements, contractual restrictions and other factors. The
amounts involved have been and may continue to be material.
The following table summarizes our liquidity as of June 30, 2021 and
December 31, 2020:
(In millions)                    As of June 30, 2021       As of December 31, 2020
Cash and cash equivalents       $              616.2      $                  649.5
Revolving credit availability                  351.6                         279.9
Liquidity                       $              967.8      $                  929.4



As of June 30, 2021, approximately 80% of the Company's cash and cash
equivalents resided outside the United States.
Expected sources of cash needed to satisfy cash requirements for the remainder
2021 include our cash on hand, cash from operations and available liquidity
under our revolving credit facility, if needed. Expected uses of cash for the
remainder of 2021 include the acquisition of Magna Colours Ltd., integration
costs related to the Clariant MB Acquisition, interest payments, cash taxes,
dividend payments, share repurchases, environmental remediation costs, capital
expenditures and debt repayment.
Cash Flows
The following describes the significant components of cash flows from operating,
investing and financing activities for the six months ended June 30, 2021 and
2020.

20 AVIENT CORPORATION
--------------------------------------------------------------------------------

Operating Activities - In the six months ended June 30, 2021, net cash provided
by operating activities was $68.1 million as compared to net cash provided by
operating activities of $76.0 million for the six months ended June 30, 2020,
driven by increased working capital requirements to meet demand and no earnout
liabilities paid during the six months ended June 30, 2021.
Investing Activities - Net cash used by investing activities during the six
months ended June 30, 2021 of $44.1 million primarily reflects capital
expenditures of $42.1 million.
Net cash used by investing activities during the six months ended June 30, 2020
of $9.0 million primarily reflects capital expenditures of $21.3 million,
partially offset by the receipt of the working capital settlement of $7.1
million related to the PP&S divestiture, and $5.2 million cash proceeds from
other assets.
Financing Activities - Net cash used by financing activities for the six months
ended June 30, 2021 of $51.6 million primarily reflects $38.8 million of
dividends paid, repurchases of our outstanding common shares of $4.2 million,
and the payment of withholding tax on share awards of $4.2 million.
Net cash provided by financing activities for the six months ended June 30, 2020
of $1,049.8 million primarily reflects $496.1 million of net proceeds received
from the issuance of common shares in an underwritten public offering that we
completed in February 2020, and $640.8 million of net proceeds from the senior
secured notes offering completed in May 2020, offset by $34.3 million of
dividends paid, repurchases of our outstanding common shares of $13.6 million,
and the payment of the Fiber-Line acquisition date earnout liability of $32.9
million.
Debt
As of June 30, 2021, our principal amount of debt totaled $1,887.8 million.
Aggregate maturities of the principal amount of debt for the current year, next
four years and thereafter, are as follows:
(In millions)
2021                       $    16.0
2022                             8.5
2023                           608.6
2024                             8.6
2025                           658.7
Thereafter                     587.4
Aggregate maturities       $ 1,887.8



As of June 30, 2021, we were in compliance with all customary financial and
restrictive covenants pertaining to our debt. For additional information
regarding our debt, please see Note 8, Financing Arrangements to the
accompanying condensed consolidated financial statements.
Derivatives and Hedging
We are exposed to market risks, such as changes in foreign currency exchange
rates and interest rates. To manage the volatility related to these exposures we
may enter into various derivative transactions. For additional information
regarding our derivative instruments, please see Note 11, Derivatives and
Hedging to the accompanying condensed consolidated financial statements.
Contractual Obligations
We have future obligations under various contracts relating to debt and interest
payments, operating leases, pension and post-retirement benefit plans and
purchase obligations. During the six months ended June 30, 2021, there were no
material changes to these obligations as reported in our Annual Report on
Form 10-K for the year ended December 31, 2020.


21 AVIENT CORPORATION
--------------------------------------------------------------------------------

CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
In this Quarterly Report on Form 10-Q, statements that are not reported
financial results or other historical information are "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements give current expectations or forecasts of
future events and are not guarantees of future performance. They are based on
management's expectations that involve a number of business risks and
uncertainties, any of which could cause actual results to differ materially from
those expressed in or implied by the forward-looking statements. You can
identify these statements by the fact that they do not relate strictly to
historic or current facts. They use words such as "will," "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and other words and
terms of similar meaning in connection with any discussion of future operating
or financial condition, performance and/or sales. In particular, these include
statements relating to future actions; prospective changes in raw material
costs, product pricing or product demand; future performance; estimated capital
expenditures; results of current and anticipated market conditions and market
strategies; sales efforts; expenses; the outcome of contingencies such as legal
proceedings and environmental liabilities; and financial results. Factors that
could cause actual results to differ materially from those implied by these
forward-looking statements include, but are not limited to:
•disruptions, uncertainty or volatility in the credit markets that could
adversely impact the availability of credit already arranged and the
availability and cost of credit in the future;
•the effect on foreign operations of currency fluctuations, tariffs and other
political, economic and regulatory risks;
•the current and potential future impact of the COVID-19 pandemic on our
business, results of operations, financial position or cash flows, including
without limitation, any supply chain and logistics issues;
•changes in polymer consumption growth rates and laws and regulations regarding
plastics in jurisdictions where we conduct business;
•fluctuations in raw material prices, quality and supply, and in energy prices
and supply;
•production outages or material costs associated with scheduled or unscheduled
maintenance programs;
•unanticipated developments that could occur with respect to contingencies such
as litigation and environmental matters;
•an inability to achieve the anticipated financial benefit from initiatives
related to acquisition and integration working capital reductions, cost
reductions and employee productivity goals;
•our ability to pay regular quarterly cash dividends and the amounts and timing
of any future dividends;
•information systems failures and cyberattacks;
•our ability to consummate and successfully integrate acquisitions;
•amounts for cash and non-cash charges related to restructuring plans that may
differ from original estimates, including because of timing changes associated
with the underlying actions; and
•other factors described in our Annual Report on Form 10-K for the year ended
December 31, 2020 under Item 1A, "Risk Factors."
We cannot guarantee that any forward-looking statement will be realized,
although we believe we have been prudent in our plans and assumptions.
Achievement of future results is subject to risks, uncertainties and
assumptions. Should known or unknown risks or uncertainties materialize, or
should underlying assumptions prove inaccurate, actual results could vary
materially from those anticipated, estimated or projected. Investors should bear
this in mind as they consider forward-looking statements. We undertake no
obligation to publicly update forward-looking statements, whether as a result of
new information, future events or otherwise, except as otherwise required by
law. You are advised, however, to consult any further disclosures we make on
related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the
Securities and Exchange Commission. You should understand that it is not
possible to predict or identify all risk factors. Consequently, you should not
consider any such list to be a complete set of all potential risks or
uncertainties.

© Edgar Online, source Glimpses